159 related articles for article (PubMed ID: 19184624)
1. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100.
Maghsoodi M
AAPS PharmSciTech; 2009; 10(1):120-8. PubMed ID: 19184624
[TBL] [Abstract][Full Text] [Related]
2. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
Maghsoodi M; Esfahani M
Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
4. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
Rawat M; Saraf S; Saraf S
AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
[TBL] [Abstract][Full Text] [Related]
5. Preparation of sustained-release nitrendipine microspheres with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method.
Yang Ms; Cui Fd; You Bg; Fan Yl; Wang L; Yue P; Yang H
Int J Pharm; 2003 Jun; 259(1-2):103-13. PubMed ID: 12787640
[TBL] [Abstract][Full Text] [Related]
6. In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug-polymer interactions.
Alhnan MA; Basit AW
J Pharm Sci; 2011 Aug; 100(8):3284-3293. PubMed ID: 21500197
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic Particle Engineering of Hydrophobic Drug with Eudragit E100─Bridging the Amorphous and Crystalline Gap.
Shikha S; Lee YW; Doyle PS; Khan SA
Mol Pharm; 2022 Nov; 19(11):4345-4356. PubMed ID: 36268657
[TBL] [Abstract][Full Text] [Related]
8. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
9. Cationic Eudragit® polymers as excipients for microparticles prepared by solvent evaporation method.
Vysloužil J; Bavoľárová J; Kejdušová M; Vetchý D; Dvořáčková K
Ceska Slov Farm; 2013 Dec; 62(6):249-54. PubMed ID: 24393112
[TBL] [Abstract][Full Text] [Related]
10. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
11. Drug distribution in enteric microparticles.
Nilkumhang S; Alhnan MA; McConnell EL; Basit AW
Int J Pharm; 2009 Sep; 379(1):1-8. PubMed ID: 19505543
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in-vitro evaluation of floating microballoons of indomethacin.
Bhardwaj P; Chaurasia H; Chaurasia D; Prajapati SK; Singh S
Acta Pol Pharm; 2010; 67(3):291-8. PubMed ID: 20524432
[TBL] [Abstract][Full Text] [Related]
13. Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance.
Chiappetta DA; Carcaboso AM; Bregni C; Rubio M; Bramuglia G; Sosnik A
AAPS PharmSciTech; 2009; 10(1):1-6. PubMed ID: 19127436
[TBL] [Abstract][Full Text] [Related]
14. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
[TBL] [Abstract][Full Text] [Related]
15. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
[TBL] [Abstract][Full Text] [Related]
16. Influence of solvent composition on the miscibility and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-drying.
Paudel A; Van den Mooter G
Pharm Res; 2012 Jan; 29(1):251-70. PubMed ID: 21773852
[TBL] [Abstract][Full Text] [Related]
17. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
Nandy BC; Mazumder B
Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
[TBL] [Abstract][Full Text] [Related]
18. The effect of inorganic salt type and concentration on hydrophilic drug loading into microspheres using the emulsion/solvent diffusion method.
Yağ G; Calış S; Arıca-Yegin B
Drug Dev Ind Pharm; 2014 Mar; 40(3):390-7. PubMed ID: 23600654
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.
Alshetaili AS; Almutairy BK; Tiwari RV; Morott JT; Alshehri SM; Feng X; Alsulays BB; Park JB; Zhang F; Repka MA
Curr Drug Deliv; 2016; 13(5):730-41. PubMed ID: 26456211
[TBL] [Abstract][Full Text] [Related]
20. Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen.
Čerpnjak K; Zvonar A; Vrečer F; Gašperlin M
Drug Dev Ind Pharm; 2015; 41(9):1548-57. PubMed ID: 25308746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
